TD Cowen analyst Marc Frahm reiterated a Buy rating on Sana Biotechnology (NASDAQ: SANA)The analyst commented, "Sana reported a Q4 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE